TICKERNOMICS Sign up
Last Update: 2023-12-23 06:01:46
CorMedix Inc. ( CRMD ) https://www.cormedix.com
3.61USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-12.17%
CRMD
SPY
30.72%
-57.33%
CRMD
SPY
112.82%
-43.59%
CRMD
SPY
201.04%
-33.76%
CRMD
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
204.16
171.59
0.52
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
0.51
3121.28
2.45
-15.42
0.00
-4.14
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-37092.38
98.63
-34882.06
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
11.0636
864.44
-73.34
1.74
Other Earnings and Cash Flow Stats:
CorMedix Inc. ( CRMD ) Net Income TTM ($MM) is 406.09
CorMedix Inc. ( CRMD ) Operating Income TTM ($MM) is -36.84
CorMedix Inc. ( CRMD ) Owners' Earnings Annual ($MM) is -24.07
CorMedix Inc. ( CRMD ) Current Price to Owners' Earnings ratio is -7.06
CorMedix Inc. ( CRMD ) EBITDA TTM ($MM) is -36.50
CorMedix Inc. ( CRMD ) EBITDA Margin is -34882.06%
Capital Allocation:
CorMedix Inc. ( CRMD ) has paid 0.00 dividends per share and bought back -15.369589 million shares in the past 12 months
CorMedix Inc. ( CRMD ) has reduced its debt by 0.131063 million USD in the last 12 months
Capital Structure:
CorMedix Inc. ( CRMD ) Interest-bearing Debt ($MM) as of last quarter is 0
CorMedix Inc. ( CRMD ) Annual Working Capital Investments ($MM) are -28
CorMedix Inc. ( CRMD ) Book Value ($MM) as of last quarter is 83
CorMedix Inc. ( CRMD ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
CorMedix Inc. ( CRMD ) has 53 million in cash on hand as of last quarter
CorMedix Inc. ( CRMD ) has 7 million of liabilities due within 12 months, and long term debt 0 as of last quarter
CorMedix Inc. ( CRMD ) has 56 common shares outstanding as of last quarter
CorMedix Inc. ( CRMD ) has 0 million USD of preferred stock value
Academic Scores:
CorMedix Inc. ( CRMD ) Altman Z-Score is 9.75 as of last quarter
CorMedix Inc. ( CRMD ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
CorMedix Inc. ( CRMD ) largest shareholder is Millennium Management LLC owning 373493 shares at 1.35 ($MM) value
Joseph Todisco(an insider) Bought 10000 shares of CorMedix Inc. ( CRMD ) for the amount of $37100.00 on 2023-09-08
0.92% of CorMedix Inc. ( CRMD ) is held by insiders, and 32.72% is held by institutions
CorMedix Inc. ( CRMD ) went public on 2010-03-25
Other CorMedix Inc. ( CRMD ) financial metrics:
FCF:-31.47
Unlevered Free Cash Flow:-26.28
EPS:-0.69
Operating Margin:-37092.38
Gross Profit Margin:98.63
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-46.85
Beta:1.74
Buffet's Owners Earnings:-24.07
Price to Owner's Earnings:-7.06
About CorMedix Inc. ( CRMD ) :
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.